What is ANI Pharmaceuticals's finance lease liabilities?

ANI Pharmaceuticals (ANIP) reported finance lease liabilities of $48K in Q4 2025.

What does finance lease liabilities mean?

Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.

ANI Pharmaceuticals ANIP Finance Lease Liabilities

Finance Lease Liabilities at other companies

Amneal Pharmaceuticals, Inc.AMRX

$58.37M-2.9%

Aurinia PharmaceuticalsAUPH

$48.18M-15.2%

Catalyst PharmaceuticalCPRX

$0—

Alumis Inc.ALMS

$0—

IncyteINCY

$29.41M-9.9%

AptarGroupATR

$24.32M+3.9%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The official record: ANI Pharmaceuticals’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's finance lease liabilities?: ANI Pharmaceuticals (ANIP) reported finance lease liabilities of $48K in Q4 2025.
What does finance lease liabilities mean?: Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.